Back to Search
Start Over
Patent Application Titled 'Uses Of Bcl-2 Antagonists For Treating Cancer And Diagnostics Related Thereto' Published Online (USPTO 20190328729)
- Source :
- Cancer Weekly. November 19, 2019, 819
- Publication Year :
- 2019
-
Abstract
- 2019 NOV 19 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application by [...]
- Subjects :
- Cabazitaxel
Ixazomib
Ceritinib
Cobimetinib
Ruxolitinib -- Intellectual property
Acalabrutinib -- Intellectual property
Romiplostim -- Intellectual property
Siltuximab
Glucarpidase
Alectinib
Aminolevulinic acid -- Intellectual property
Midostaurin -- Intellectual property
BCR-ABL tyrosine kinase inhibitors
Ramucirumab
Trifluridine -- Intellectual property
Olaparib
Nivolumab
Carboplatin -- Intellectual property
Obinutuzumab
Lanreotide
Methylnaltrexone
Brigatinib -- Intellectual property
Rasburicase -- Intellectual property
Pamidronate -- Intellectual property
Axicabtagene ciloleucel -- Intellectual property
Enasidenib -- Intellectual property
Osimertinib
Palifermin -- Intellectual property
Cancer
Monoclonal antibodies
Pembrolizumab
Inotuzumab ozogamicin -- Intellectual property
Belinostat
Neratinib -- Intellectual property
Zoledronic acid
Decitabine
Copanlisib -- Intellectual property
Durvalumab -- Intellectual property
Palbociclib
Idelalisib
Blinatumomab
Bevacizumab -- Intellectual property
Antiemetics -- Intellectual property
Plerixafor
Abemaciclib -- Intellectual property
Eltrombopag -- Intellectual property
Talimogene laherparepvec
Antineoplastic agents -- Intellectual property
Afatinib
Temsirolimus
Cabozantinib
Fulvestrant
Pertuzumab
Dasatinib
Nelarabine
Axitinib
Ibrutinib
Sonidegib
Nilotinib
Abiraterone
Dabrafenib
Pemetrexed
Pomalidomide
Carfilzomib
Olaratumab
Enzalutamide
Sunitinib
Niraparib
Crizotinib
Necitumumab
Lapatinib
Dinutuximab
Ponatinib
Bosutinib
Rucaparib
Ofatumumab
Sorafenib
Bendamustine
Trametinib
Vemurafenib
Tumors
Ribociclib
Aflibercept
Panobinostat
Cancer treatment
Anopheles
Clofarabine
Ixabepilone
Vincristine
Editors
Lenvatinib
Rolapitant
Vandetanib
Aprepitant
Cetuximab
Atezolizumab
Romidepsin
Ipilimumab
Venetoclax
Trabectedin
Vismodegib
Elotuzumab
Pralatrexate
Regorafenib
Degarelix
Everolimus
Vorinostat
Avelumab
Palonosetron
Panitumumab
Brentuximab vedotin
Ibritumomab tiuxetan
Denosumab
Pazopanib
Daratumumab
Business
Health
Health care industry
Subjects
Details
- Language :
- English
- ISSN :
- 15324567
- Database :
- Gale General OneFile
- Journal :
- Cancer Weekly
- Publication Type :
- News
- Accession number :
- edsgcl.605997469